 |
|
|
||||||||||||||||||||||||||||||||
|
Nanotech News
Additional Publications of Note
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors.
A cell nanoinjector based on carbon nanotubes.
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.
Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy.
Facile production of multivalent enzyme-nanoparticle conjugates.
A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging.
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
Cell-penetrating-peptide-coated nanoribbons for intracellular nanocarriers.
Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Ligand-conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo.
Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin.
Nanotechnology platforms and physiological challenges for cancer therapeutics.
Nanotechnology applications in cancer.
Exploiting nanotechnology to target cancer.
Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability.
Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity.
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells.
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.
Design and creation of new nanomaterials for RNAi.
Using luminescent nanoparticles as staining probes for Affymetrix GeneChips.
A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.
Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas.
Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen.
Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. |
|||||||||||||||||||||||||||||||||
